ovel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trial
Not Applicable
- Conditions
- refractory neuroblastoma
- Registration Number
- JPRN-UMIN000029816
- Lead Sponsor
- Mie University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
patients who have paralysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety (paralysis) and efficacy (anti-tumor effect) at 6 months after administration
- Secondary Outcome Measures
Name Time Method